Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Confidential contracting

- PMLiVE

Good Relations appoints new executive director

Sophie Taylor-Roberts will head the agency’s health and wellbeing practice

- PMLiVE

Lucid launches rare and specialist disease agency

Vivid MedComms will be headed by Alison Cantle

IFPMA names new communications director

Helen Gallagher joins the association from Ferring Pharmaceuticals

European venture funding for the life science sector

Trends in healthcare

- PMLiVE

Effective sales performance

The role of targeting

- PMLiVE

Transforming Access to Medicines Through Patient-Centric Solutions

As medicines access evolves and pharmaceutical companies take an increasingly nuanced approach to it, it’s ever-more important to focus on particular aspects of this area and investigate whether firms are...

Prime Global expands Core’s senior team

Norbert Brunhuber joins as director of client services

Sanofi reception

Sanofi licences Principia MS drug in $805m deal

Californian biotech is set to receive $765m plus in milestone payments if PRN2246 goes to market

- PMLiVE

QuintilesIMS changes its name to IQVIA

Firm will focus on human data science solutions

- PMLiVE

Porterhouse Medical expands into the US

UK med comms group opens new subsidiary in Philadelphia

AstraZeneca AZ

AZ CEO says company’s renaissance is on track

Soriot insists AZ’s strategy is working and will continue

Magic of Lucid targets rare and specialist diseases

Lucid Group, the award-winning global medical communications company with offices in London, Buckinghamshire, Macclesfield and New York, has announced the launch of a new agency specialising in rare and specialist...

Lucid Group Communications Limited

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links